JPS5959689A - Furo(2,3-b)indolizine derivative and its preparation - Google Patents

Furo(2,3-b)indolizine derivative and its preparation

Info

Publication number
JPS5959689A
JPS5959689A JP17024882A JP17024882A JPS5959689A JP S5959689 A JPS5959689 A JP S5959689A JP 17024882 A JP17024882 A JP 17024882A JP 17024882 A JP17024882 A JP 17024882A JP S5959689 A JPS5959689 A JP S5959689A
Authority
JP
Japan
Prior art keywords
compound
lower alkyl
group
halogen
indolizine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17024882A
Other languages
Japanese (ja)
Other versions
JPH0160474B2 (en
Inventor
Shoichi Kakehi
筧 昭一
Suketaka Itou
伊東 祐隆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP17024882A priority Critical patent/JPS5959689A/en
Publication of JPS5959689A publication Critical patent/JPS5959689A/en
Publication of JPH0160474B2 publication Critical patent/JPH0160474B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIALA compound shown by the formul I [R is H, lower alkyl, or (halogen-substituted) phenyl; Y is H, halogen, lower alkyl, or phenyl). EXAMPLE:3-(2,2-Dicyanovinyl)-1-methyl-2-(phenacyloxy)indolizine. USE:An antiallergic, inhibitor of blood platelet aggregation, and anti-inflammatory agent. PROCESS:A pyridinium compound shown by the formula II(R1 is lower alkyl; X is halogen) is reacted with preferably 1-twice equivalent amount of a basic compound (e.g., sodium methoxide, etc.), and reacted with ethoxymethlene malodinitrile and a halogen compound shown by the formula III (preferably 1- twice equivalent amount, respectively), to give a vinylindolizine derivative shown by the formula IV. This compound is treated with a basic compound (preferably NaOH, etc.), to give a compound shown by the formula I .

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は新規なフロ[2,3−b]イントリジン誘専体
及びその製造法に関する。 本発明省らは、かねてより特定のピリジニウム化合物を
出発原料としζ得られる一連のインドリジン誘導体につ
い°ζ種々研究を重ねてきたが、その過程において下記
反応工程式に示すように、原料とするピリジニウム化合
物から容易に文献未記載のフロ[2,3−b]インドリ
ジン誘導体が収得できるという事実を見いだした。 本
発明はかかる新しい知見に基づいて完成されたものであ
る。 本発明のフロ[2,3−blインドリジン誘導体は下記
−・般式(1)で示される。 (式中、Rは水素原子、低級アルキル基、フェニル基又
は置換基としてハロゲン原子を有するフェニル基を、Y
は水素原子、ハロゲン原子、低級アルキル基、又はフェ
ニル基を意味する。)上記一般式(1)中、R及びYで
定義される低級アルキル基としては、炭素数1−6のア
ルキル基、例えばメチル、エチル、プロピル、ブチル、
ヘキシル基等を例示できる。Rで定義されるフェニル基
の置換基であるハロゲン原子及びYで定義されるハロゲ
ン原子としては、塩素、臭素、弗素沃素原子を例示でき
る。 上記一般式(1)で示される本発明化合物ば抗アレルギ
ー作用、血小板凝集抑制作用、抗炎症作用等を有し医薬
として有用である。 以下、本発明化合物の製造法につき説明する。 本発明化合物は例えば下記反応工程式に示す方法に従い
製造される。
The present invention relates to a novel furo[2,3-b]intolidine derivative and a method for producing the same. The Ministry of the Invention and others have long conducted various studies on a series of indolizine derivatives obtained using a specific pyridinium compound as a starting material, and in the process, as shown in the reaction scheme below, It has been discovered that a furo[2,3-b]indolizine derivative, which has not been described in any literature, can be easily obtained from a pyridinium compound. The present invention was completed based on this new knowledge. The furo[2,3-bl indolizine derivative of the present invention is represented by the following general formula (1). (In the formula, R is a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl group having a halogen atom as a substituent, and Y
means a hydrogen atom, a halogen atom, a lower alkyl group, or a phenyl group. ) In the above general formula (1), the lower alkyl group defined by R and Y includes an alkyl group having 1 to 6 carbon atoms, such as methyl, ethyl, propyl, butyl,
Examples include hexyl group. Examples of the halogen atom that is a substituent of the phenyl group defined by R and the halogen atom defined by Y include chlorine, bromine, and fluorine iodine atoms. The compound of the present invention represented by the above general formula (1) has antiallergic action, platelet aggregation inhibiting action, antiinflammatory action, etc., and is useful as a medicine. The method for producing the compound of the present invention will be explained below. The compound of the present invention can be produced, for example, according to the method shown in the following reaction scheme.

【反応T程式】[Reaction T equation]

(式中、R及びYは前記と同しであり、1ン1は低級ア
ルキル尽を、Xはハロゲン原子を意味する。)即ち、本
発明化合物の製造は出発原料のピリジニウム化合物(I
I )から中間体のビニルインドリジン誘導体(rV)
を得る第1工程と、1′ビニルイントリジン誘導体(■
)からフロ[2,3−b)インドリジン誘導体(1)を
得る第2工程とからなる。 第1工程 ピリジニウム化合物(n)に塩41性化合物を作用させ
た後、工トキジノチレンマロンジニトリル及びハロゲン
化合物(Tll)を反LE、させて、ビニルイントリジ
ン誘導体(rV)を(qる。塩基性化合物としては、例
えばナトリウムメトキシド、ナトリウノ、工]・キシド
、ナ1−リウムプロボキシト等の金属アルコキシド、水
酸化ナトリウム、水酸化カリウム等の水酸化アルカリ、
炭酸すトリウム、炭酸カリウム等の炭酸アルカリ等が挙
げられる。 塩基性化合物の使用mは適宜選択することができるが、
−・般にピリジニウム化合物(11)に対して1−2缶
内m程度使用するのが有利である。上記ビリジニラJ、
化合物(II)と塩基性化合物との反応は通常、溶媒中
で行われる。溶媒としては、不活性な溶媒であれば特に
限定されないが、例えばメタノール、エタノール、プロ
パツール等の低級アルコール類、ジオキサン、テトラ上
1−ロフラン等のエーデルチn、ジメチルホルムアミド
、ジメチルスルホキシト等の非プロ1−ン性極性l容媒
類等の中から使用するピリジニウム化合物(II)及び
塩基性化合物の挿顛により適宜選択して使用される。 
反応2M4度は’15に限定されないが、通常50−7
0°0イ\1近でおこフ、(うと反応は有利に進行する
。 塩)占性化合物を数分間反応させた後、工l−キシメチ
レンマし1ンジニトリル及びハロゲン化合物(III)
を順次加える。エトキシメチレンマし1ンシニトリル及
びハロゲン化合物(III)の使用量は適宜選択するこ
とができるが、一般にピリジニウム化合物(II)に対
しそれぞれ1−2缶内量程度使用するのが有利である。 50−70℃で0.5−5時間反応さゼると、ビニルイ
ントリジン誘導体(1■)が生成し、これは通常の分離
手段により容易に中部可能である。 第2工程 ビニルインドリジン誘導体(TV)に塩基性化合物を作
用させて本発明化合物のフロ[2,3−b]インドリジ
ン誘導体(+)を得る。塩基性化合物としては−jlT
hに氷に78f!/i′シた水酸化すトリウム、水酸化
カリウム等の水酸化アルカリがH適に使用される。 塩基性化合物の使用量は適宜選択することができるが、
一般にビニルイントリジン誘導体(IV)にタ1して5
−50倍缶内程度使用するのが有利である。」二記ヒニ
ルインドリジン誘導体(N)と塩基性化合物との反応は
通雷、溶媒中で行われる。、溶媒としては、不活性溶媒
であれば特に限定されないが、例えば第1工稈で示した
溶媒が使用できる。反応’IXA度は特に限定されない
が、通雷50−7 (1℃(マJ近でおこなうのが有利
である。」二記反応により化合物(+)が生成し、これ
は適音の分離手段により容易に単離可能である。 又、本発明化合物(1)は中間体ビニルイン1リジン誘
導体(1v)を反応系から中部することなく、第1工稈
と第2工程をそのまま連続して行うことによっても全く
同様乙こ製造することが可能である。 以下、本発明の一般式([)で示されるフロ[2,3−
b’lイントリジン誘導体の代表的化合物の物理化学的
定数を表1及び表2に示し、次いで実施例 尚、表1中収率の項の()内の数字しま、中間体(IV
)を単離しない製造法Gこよる1叉率を示す。 以下余白 実施例 1 ■−エトキシ力ルポニルー2−エチルピリジニウムプロ
ミド0.822g (3ミリモル)をエタノール50m
1に/8解したのち、50−70℃です]・リウノ、エ
トキシド−エタノール/8液5 rn 1(6ミリモル
のナトリウムエトキシドを含む)を加える。2−3分後
、エトキシメチレンマロンジニトリル0.366g (
3ミリモル)を加え攪拌する。3分後、フェナシルプロ
ミド0.100g(3,5ミリモル)を加え50−70
℃で3時間攪拌する。反応混合物を水中に注ぎ、析出す
る結晶を濾取、乾燥した後クロロホルムより再結晶し7
て3− (2,2−ジシアノビニル)−1−メチル−2
−(フェナシルオキシ)インドリジン0.624gを得
た。(収率61%) m、p  225 227℃ 元素分析(C2+H15N302として)CHN 計算値(%”)73.89 4.43 12.3]実測
値(%)73.8]  4.37 12.44実施例 
2−4 実施例 1と同様の方法により以下のビニルインドリジ
ン誘導体を得た。 3− (2’、2−ジシアノビニル)−2−(フェナシ
ルオキシ)インドリジン m、p  211−213°C 元素分析(C2oH+3N302として)CHN 計算値(%)73.38 4.00 12.84実測値
(%)73.53 4.10 12.603−(2,2
−ジシアノビニル)−1−エチル−2−(フェナシルオ
キシ)インドリジンm、p   203−207℃ 元素分析(C22HI yN302として)CHN 計算値(%)74.35 4.82  ’11.82実
測値(%)74.28 4.93 11.78:3− 
(2,2−ジシアノビニル)−2−(フェナシルオキシ
)−1−フェニルインドリジンm、p  198 20
1℃ 元素分析(C26H17N302として)CHN B1算値(%)77.41 4.25 10.42実測
値(%)77.37 4.19 10.51実施例 5 3− (2,2−ジシアノビニル)−1−メチル−2−
(フェナシルオキシ)インドリジン0.341g (1
ミリモル)をエタノール50m1に加え5分間攪拌した
のち水中に注ぐ、濃塩酸で中和したのちクロロホルム抽
出し、無水硫酸ナトリムで乾燥する。溶媒を留去し、残
査をアルミナカラムを用いて分離し、次にエタノールか
ら再結晶して2−ベンゾイル−9−メチルフロ[2,3
−b]インドリジン(化合物2)0.261gを得た。 (収率95%) 実施例 6 2−ベンジル−1−(エトキシカルボニルメチル)ピリ
ジニウムプロミド1.008g (3ミリモル)をエタ
ノール5 ’Om +に加熱溶解したのちナトリウムエ
トキシド−エタノール溶液6m1(6ミリモルのナトリ
ウムエトキシドを含む)を加え攪拌する。3分後、エト
キシメチレンマロンジニトリル0.366g (3ミリ
モル)を加え攪拌する。3分後、更にp−クロルフエナ
シルブロミド0.l112g (3,5ミリモル)を加
え、50−70”Cで3時間攪拌する。次に水酸化カリ
ウム溶液5m1 (水酸化カリウム2gを含む)を加え
、攪拌する。5分後、反応混合物を水中に注ぎ、濃塩酸
で中和する。クロロホルム抽出し、無水硫酸硫酸ナトリ
ムで乾燥したのち溶媒を留去する。 残査をアルミナカラムを用いて分離し、ついでクロロポ
ルム−エタノールから再結晶して2−(p−クロルヘン
ジイル)−9−フェニルフロ[23−b]イントリジン
(化合物9)0.346gを得た。 (収率3+910
(In the formula, R and Y are the same as above, 1-1 means lower alkyl, and X means a halogen atom.) That is, the production of the compound of the present invention is carried out using the pyridinium compound (I
I) to intermediate vinyl indolizine derivative (rV)
The first step is to obtain a 1′ vinylintolidine derivative (■
) to obtain the furo[2,3-b) indolizine derivative (1). First step: After treating the pyridinium compound (n) with a salt-41 compound, the engineered tokydinothylene malondinitrile and the halogen compound (Tll) are reacted with anti-LE to form the vinyl intridine derivative (rV). Examples of basic compounds include metal alkoxides such as sodium methoxide, sodium oxide, sodium proboxoxide, alkali hydroxides such as sodium hydroxide and potassium hydroxide,
Examples include alkali carbonates such as thorium carbonate and potassium carbonate. The basic compound used m can be selected as appropriate, but
- Generally, it is advantageous to use about 1-2 m per can of pyridinium compound (11). The above Viriginilla J,
The reaction between compound (II) and a basic compound is usually carried out in a solvent. The solvent is not particularly limited as long as it is an inert solvent, but examples include lower alcohols such as methanol, ethanol, and propatool; The pyridinium compound (II) and the basic compound are appropriately selected from polar polar media and the like.
The reaction 2M4 degree is not limited to '15, but is usually 50-7
When the temperature approaches 0°0\1, the reaction proceeds favorably. After reacting the salt-occupying compound for several minutes, the mixture of l-ximethylene, dinitrile and halogen compound (III) is formed.
Add sequentially. The amounts of ethoxymethylene, cinnitrile, and halogen compound (III) to be used can be selected as appropriate, but it is generally advantageous to use about 1 to 2 cans of each relative to pyridinium compound (II). After reacting for 0.5-5 hours at 50-70°C, a vinyl intolidine derivative (1) is formed, which can be easily separated by conventional separation means. Second Step A basic compound is allowed to act on the vinyl indolizine derivative (TV) to obtain the furo[2,3-b]indolizine derivative (+) of the compound of the present invention. -jlT as a basic compound
78f on ice at h! Alkali hydroxides such as thorium hydroxide and potassium hydroxide are suitably used. The amount of the basic compound used can be selected as appropriate, but
In general, vinyl intridine derivatives (IV) are combined with 5
- It is advantageous to use about 50 times the amount in the can. The reaction between the hinyl indolizine derivative (N) and the basic compound is carried out under lightning in a solvent. The solvent is not particularly limited as long as it is an inert solvent, and for example, the solvents shown in the first culm can be used. The degree of reaction 'IXA is not particularly limited, but it is advantageous to carry out the reaction at a temperature of 50-7 (1°C) near MaJ.' The second reaction produces a compound (+), which can be used as a suitable separation means. The compound (1) of the present invention can be easily isolated by directly carrying out the first culm and the second step without removing the intermediate vinylyne-1-lysine derivative (1v) from the reaction system. It is also possible to produce the product in exactly the same manner by
The physicochemical constants of representative compounds of b'l intolidine derivatives are shown in Tables 1 and 2, and then in Examples, the number stripes in parentheses in the yield section in Table 1 indicate the intermediate (IV
) is shown in Table 1. Example 1 in the blank space below ■-Ethoxyluponyl-2-ethylpyridinium bromide 0.822g (3 mmol) was added to 50ml of ethanol.
1/8, then at 50-70°C] - Add Riuno, ethoxide-ethanol/8 solution 5 rn 1 (containing 6 mmol of sodium ethoxide). After 2-3 minutes, 0.366 g of ethoxymethylenemalondinitrile (
3 mmol) and stir. After 3 minutes, add 0.100 g (3.5 mmol) of phenacylbromide to 50-70
Stir at ℃ for 3 hours. The reaction mixture was poured into water, the precipitated crystals were collected by filtration, dried, and recrystallized from chloroform.
3-(2,2-dicyanovinyl)-1-methyl-2
-(Phenacyloxy)indolizine 0.624 g was obtained. (Yield 61%) m, p 225 227°C Elemental analysis (as C2+H15N302) CHN Calculated value (%”) 73.89 4.43 12.3] Actual value (%) 73.8] 4.37 12.44 Example
2-4 The following vinyl indolizine derivatives were obtained in the same manner as in Example 1. 3- (2',2-dicyanovinyl)-2-(phenacyloxy)indolizine m, p 211-213°C Elemental analysis (as C2oH+3N302) CHN Calculated value (%) 73.38 4.00 12.84 Actual value (%) 73.53 4.10 12.603-(2,2
-dicyanovinyl)-1-ethyl-2-(phenacyloxy)indolizine m, p 203-207°C Elemental analysis (as C22HI yN302) CHN Calculated value (%) 74.35 4.82 '11.82 Actual value (%) 74.28 4.93 11.78:3-
(2,2-dicyanovinyl)-2-(phenacyloxy)-1-phenylindolizine m, p 198 20
1°C Elemental analysis (as C26H17N302) CHN B1 calculated value (%) 77.41 4.25 10.42 Actual value (%) 77.37 4.19 10.51 Example 5 3- (2,2-dicyanovinyl )-1-methyl-2-
(Phenacyloxy)indolizine 0.341g (1
mmol) was added to 50 ml of ethanol, stirred for 5 minutes, and poured into water. Neutralized with concentrated hydrochloric acid, extracted with chloroform, and dried over anhydrous sodium sulfate. The solvent was distilled off, the residue was separated using an alumina column, and then recrystallized from ethanol to give 2-benzoyl-9-methylfuro[2,3
-b] 0.261 g of indolizine (compound 2) was obtained. (Yield 95%) Example 6 1.008 g (3 mmol) of 2-benzyl-1-(ethoxycarbonylmethyl)pyridinium bromide was heated and dissolved in ethanol 5'Om+, and then 6 ml (6 ml) of sodium ethoxide-ethanol solution was added. (containing mmol of sodium ethoxide) and stir. After 3 minutes, 0.366 g (3 mmol) of ethoxymethylenemalondinitrile is added and stirred. After 3 minutes, add 0.0% p-chlorphenacyl bromide. Add 112 g (3.5 mmol) of potassium hydroxide and stir for 3 hours at 50-70"C. Then add 5 ml of potassium hydroxide solution (containing 2 g of potassium hydroxide) and stir. After 5 minutes, pour the reaction mixture into water. The mixture was poured into water and neutralized with concentrated hydrochloric acid. Extracted with chloroform, dried over anhydrous sodium sulfate, and then the solvent was distilled off. The residue was separated using an alumina column, and then recrystallized from chloroporum-ethanol to obtain 2- 0.346 g of (p-chlorohendiyl)-9-phenylfuro[23-b]intolidine (compound 9) was obtained. (Yield 3+910
)

Claims (1)

【特許請求の範囲】[Claims] (1)一般式 (式中、Rは水素原子、低級アルキル基、フェニル基又
は置換基としてハロゲン原子を有するフェニル県を、Y
は水素原子、ハロゲン原子、低級フルキル基、又はフェ
ニル基を意味する。)で示されるフロ[2,1−b]イ
ントリジン誘導体(2)一般式 (式中、Rは水素原子、低級アルキル基、フェニル基又
は置襖基としてハロゲン原子を有するフェニル基を、Y
は水素原子、ハロゲン原子、低級アルキル基、又は)1
.ニル基を意味する。)で示されるビニルインドリジン
誘導体に塩基性化合物を作用させることを特徴とする、
一般式 (式中、R及びYは前記と同し。)で示されるフロ[2
,3−b]インドリジン誘導体の製造法(3)  −f
l>式 (式中、Rは水素原子、低級アルキル基、フェニル基又
は置換基表してハロゲン原子を有する)−Zニル基を、
R、は低級アルキル基を、Xはハロゲン原子を意味する
。)で示されるピリジニウム化合物に、塩基性化合物を
作用させるとともに、工1−キシメチレンマロンジニト
リル及び一般式(式中、Xはハロゲン原子を、Yは水素
原子、ハロゲン原子、低級アルキル基又はフェニル基を
意味する。)で示されるノ\ロゲン化合物を反応させて
一般式 (式中、R及びYは前記と同し。)で示されるビニルイ
ンドリジン誘導体となし、次いで塩基性化合物を作用さ
せることを特徴とする、一般式式中、!′2及びYは前
記と間し。)で示されるフロ[2,3−11]インドリ
ジン誘導体の製造法
(1) General formula (wherein R is a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl group having a halogen atom as a substituent, Y
means a hydrogen atom, a halogen atom, a lower fulkyl group, or a phenyl group. ) Furo[2,1-b]intolidine derivative (2) general formula (wherein, R is a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl group having a halogen atom as a substituent group, Y
is a hydrogen atom, a halogen atom, a lower alkyl group, or)1
.. means nyl group. ) is characterized by causing a basic compound to act on the vinyl indolizine derivative represented by
Furo[2] represented by the general formula (wherein R and Y are the same as above)
, 3-b] Method for producing indolizine derivative (3) -f
l> Formula (wherein R represents a hydrogen atom, a lower alkyl group, a phenyl group, or a substituent having a halogen atom) -Znyl group,
R represents a lower alkyl group, and X represents a halogen atom. ), a basic compound is applied to the pyridinium compound represented by ) is reacted to form a vinylindolizine derivative represented by the general formula (wherein R and Y are the same as above), and then treated with a basic compound. In the general formula, which is characterized by,! '2 and Y are between the above. ) A method for producing a furo[2,3-11]indolizine derivative represented by
JP17024882A 1982-09-29 1982-09-29 Furo(2,3-b)indolizine derivative and its preparation Granted JPS5959689A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17024882A JPS5959689A (en) 1982-09-29 1982-09-29 Furo(2,3-b)indolizine derivative and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17024882A JPS5959689A (en) 1982-09-29 1982-09-29 Furo(2,3-b)indolizine derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS5959689A true JPS5959689A (en) 1984-04-05
JPH0160474B2 JPH0160474B2 (en) 1989-12-22

Family

ID=15901414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17024882A Granted JPS5959689A (en) 1982-09-29 1982-09-29 Furo(2,3-b)indolizine derivative and its preparation

Country Status (1)

Country Link
JP (1) JPS5959689A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07320809A (en) * 1994-05-20 1995-12-08 Oriekusu Kk Double pin locking type multipolar plug

Also Published As

Publication number Publication date
JPH0160474B2 (en) 1989-12-22

Similar Documents

Publication Publication Date Title
DE69723846T2 (en) Process for the preparation of sildenafil
US6013828A (en) Processes and intermediates useful to make antifolates
EP0000200B1 (en) New n-amidino-3,5-diamino-6-substituted-2-pyrazinecarboxamides and process for preparing same
JPS60208954A (en) Manufacture of 2,6,9-trisubstituted purines
CA1126269A (en) Process for the preparation of imidazobenzodiazepines
JPS5959689A (en) Furo(2,3-b)indolizine derivative and its preparation
JPS634544B2 (en)
US2420641A (en) Process for preparing dl-histidine and intermediates therefor
EP1730153B1 (en) Isopropanol water solvate of olanzapine
US6090168A (en) Processes and intermediates useful to make antifolates
CN110759831B (en) Method for preparing halofuginone intermediate 2-amino-4-bromo-5-chlorobenzoic acid
JPS6127977A (en) 4,5-dihydro-3,3-diphenyl-4-hydrocarbyl aminomethylfuran-2(3h)-one
US4267388A (en) Process for producing ethynylbenzenes
JP2659587B2 (en) 4-aziridinyl pyrimidine derivatives and their production
EP1471058B1 (en) Process for producing 1,2,3-triazole compound
EP0151423A2 (en) Process for the preparation of a carbazole derivative
JPS6110565A (en) Preparation of uracil-5-carboxylic acid ester
JPS60237041A (en) Preparation of 3-propionylsalicylic acid derivative
US4160092A (en) Quinazolinone oxides and their use as intermediates for pharmaceutical agents
US3183240A (en) Cxc-chj
JPH0780812B2 (en) Azulene derivative thromboxane synthetase inhibitor and process for producing the same
JPH0359065B2 (en)
US20060217554A1 (en) Processes for producing pyrazoloacridone derivative and synthetic intermediate thereof
JPH0217550B2 (en)
JPH0217549B2 (en)